Nasus Pharma Ltd - NSRX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | History | No change | 898,473 | 3,144 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |
| Cable Car Capital, LP | History | Added to | 616,081 | 2,156 | 0.05% | 0.46% | 2 | +14,083 | 2.34% | Q2 2026 | Aug 14, 2026 |
| Velan Capital Investment Management LP | History | No change | 359,390 | 1,257 | 0.77% | 0.5% | 3 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management LP | History | No change | 134,771 | 471 | 0.0% | 0.0% | 4 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |
| Bleichroeder LP | History | No change | 89,848 | 314 | 0.06% | 0.03% | 5 | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | History | New | 22,004 | 77 | 0.0% | — | 6 | +22,004 | New | Q2 2026 | Sep 02, 2026 |
| XTX Topco Ltd | History | New | 16,640 | 58 | 0.0% | — | 7 | +16,640 | New | Q2 2026 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | History | New | 12,200 | 42 | 0.0% | — | 8 | +12,200 | New | Q2 2026 | Aug 13, 2026 |
| MORGAN STANLEY | History | Reduced | 1,000 | 3 | 0.0% | 0.0% | 9 | -1,000 | -50.0% | Q2 2026 | Aug 13, 2026 |
| Empery Asset Management, LP | History | Closed out | 0 | 0 | — | 0.12% | — | -45,803 | -100.0% | Q2 2026 | Aug 11, 2026 |
| HRT FINANCIAL LP | History | Closed out | 0 | 0 | — | 0.0% | — | -38,897 | -100.0% | Q2 2026 | Aug 14, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -3,094 | -100.0% | Q2 2026 | Aug 13, 2026 |
| Caitong International Asset Management Co., Ltd | History | New | 4 | 0 | — | — | — | +4 | New | Q2 2026 | Aug 04, 2026 |